Neuro biomarker levels measured with high-sensitivity digital ELISA differ between serum and plasma
Aim: Digital ELISA-based assays for blood biomarkers of neurological disease are on the verge of clinical use. Here, we aimed to determine whether different preanalytical blood processing techniques influence results. Materials & methods: Concentrations of neurofilament light chain (NfL), Tau and amyloid beta (Aβ) were measured in human plasma and serum specimens using digital ELISA and compared between blood products. Measured levels of NfL were highly equivalant between serum and plasma in all analyses, however, measured levels of Tau and Aβ were consistently lower in serum relative to plasma. Conclusion: Tau and Aβ are likely lost during clotting in serum preparations, and should be assayed in plasma to get an accurate measure of circulating levels.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Bioanalysis - 11(2019), 22 vom: 16. Nov., Seite 2087-2094 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
O'Connell, Grant C [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Amyloid beta-Peptides |
|---|
| Anmerkungen: |
Date Completed 10.04.2020 Date Revised 01.11.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.4155/bio-2019-0213 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM304309400 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM304309400 | ||
| 003 | DE-627 | ||
| 005 | 20231225114718.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4155/bio-2019-0213 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1014.xml |
| 035 | |a (DE-627)NLM304309400 | ||
| 035 | |a (NLM)31829739 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a O'Connell, Grant C |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Neuro biomarker levels measured with high-sensitivity digital ELISA differ between serum and plasma |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.04.2020 | ||
| 500 | |a Date Revised 01.11.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Aim: Digital ELISA-based assays for blood biomarkers of neurological disease are on the verge of clinical use. Here, we aimed to determine whether different preanalytical blood processing techniques influence results. Materials & methods: Concentrations of neurofilament light chain (NfL), Tau and amyloid beta (Aβ) were measured in human plasma and serum specimens using digital ELISA and compared between blood products. Measured levels of NfL were highly equivalant between serum and plasma in all analyses, however, measured levels of Tau and Aβ were consistently lower in serum relative to plasma. Conclusion: Tau and Aβ are likely lost during clotting in serum preparations, and should be assayed in plasma to get an accurate measure of circulating levels | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a NFL | |
| 650 | 4 | |a SiMoA | |
| 650 | 4 | |a brain injury | |
| 650 | 4 | |a methods | |
| 650 | 4 | |a neurodegeneration | |
| 650 | 4 | |a single molecule array | |
| 650 | 4 | |a techniques | |
| 650 | 7 | |a Amyloid beta-Peptides |2 NLM | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 650 | 7 | |a tau Proteins |2 NLM | |
| 700 | 1 | |a Alder, Megan L |e verfasserin |4 aut | |
| 700 | 1 | |a Webel, Allison R |e verfasserin |4 aut | |
| 700 | 1 | |a Moore, Shirley M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bioanalysis |d 2009 |g 11(2019), 22 vom: 16. Nov., Seite 2087-2094 |w (DE-627)NLM196969840 |x 1757-6199 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2019 |g number:22 |g day:16 |g month:11 |g pages:2087-2094 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4155/bio-2019-0213 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2019 |e 22 |b 16 |c 11 |h 2087-2094 | ||